(4aS,7S)-7-hydroxy-1,4a-dimethyl-7-prop-1-en-2-yl-4,5,6,8-tetrahydro-3H-naphthalen-2-one

Details

Top
Internal ID c1a44956-b343-4a28-a6f2-7a4d69c4f1a5
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids
IUPAC Name (4aS,7S)-7-hydroxy-1,4a-dimethyl-7-prop-1-en-2-yl-4,5,6,8-tetrahydro-3H-naphthalen-2-one
SMILES (Canonical) CC1=C2CC(CCC2(CCC1=O)C)(C(=C)C)O
SMILES (Isomeric) CC1=C2C[C@@](CC[C@]2(CCC1=O)C)(C(=C)C)O
InChI InChI=1S/C15H22O2/c1-10(2)15(17)8-7-14(4)6-5-13(16)11(3)12(14)9-15/h17H,1,5-9H2,2-4H3/t14-,15+/m1/s1
InChI Key ILQHRBAJJAOTHE-CABCVRRESA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O2
Molecular Weight 234.33 g/mol
Exact Mass 234.161979940 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 2.30
Atomic LogP (AlogP) 3.16
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4aS,7S)-7-hydroxy-1,4a-dimethyl-7-prop-1-en-2-yl-4,5,6,8-tetrahydro-3H-naphthalen-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 + 0.9048 90.48%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability + 0.5571 55.71%
Subcellular localzation Mitochondria 0.6698 66.98%
OATP2B1 inhibitior - 0.8465 84.65%
OATP1B1 inhibitior + 0.9395 93.95%
OATP1B3 inhibitior + 0.9542 95.42%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior + 0.6250 62.50%
BSEP inhibitior - 0.8292 82.92%
P-glycoprotein inhibitior - 0.9337 93.37%
P-glycoprotein substrate - 0.9132 91.32%
CYP3A4 substrate + 0.5478 54.78%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8848 88.48%
CYP3A4 inhibition - 0.6931 69.31%
CYP2C9 inhibition - 0.8825 88.25%
CYP2C19 inhibition - 0.8333 83.33%
CYP2D6 inhibition - 0.9472 94.72%
CYP1A2 inhibition - 0.8859 88.59%
CYP2C8 inhibition - 0.9617 96.17%
CYP inhibitory promiscuity - 0.9355 93.55%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9300 93.00%
Carcinogenicity (trinary) Non-required 0.5034 50.34%
Eye corrosion - 0.9907 99.07%
Eye irritation + 0.9694 96.94%
Skin irritation + 0.5878 58.78%
Skin corrosion - 0.9657 96.57%
Ames mutagenesis - 0.7400 74.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7108 71.08%
Micronuclear - 0.9600 96.00%
Hepatotoxicity + 0.5006 50.06%
skin sensitisation + 0.5715 57.15%
Respiratory toxicity - 0.5667 56.67%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity + 0.8125 81.25%
Nephrotoxicity + 0.7640 76.40%
Acute Oral Toxicity (c) III 0.7420 74.20%
Estrogen receptor binding - 0.8779 87.79%
Androgen receptor binding - 0.5597 55.97%
Thyroid receptor binding - 0.7025 70.25%
Glucocorticoid receptor binding - 0.6823 68.23%
Aromatase binding - 0.6341 63.41%
PPAR gamma - 0.7291 72.91%
Honey bee toxicity - 0.8076 80.76%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity - 0.6500 65.00%
Fish aquatic toxicity + 0.9910 99.10%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.39% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.33% 94.45%
CHEMBL1937 Q92769 Histone deacetylase 2 88.27% 94.75%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.60% 95.56%
CHEMBL4040 P28482 MAP kinase ERK2 86.07% 83.82%
CHEMBL5966 P55899 IgG receptor FcRn large subunit p51 85.30% 90.93%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 83.02% 93.04%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 82.14% 85.14%
CHEMBL2581 P07339 Cathepsin D 81.82% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 80.96% 96.09%

Cross-Links

Top
PubChem 57335617
NPASS NPC84790
LOTUS LTS0071712
wikiData Q105115371